1. Volume 60, Issue 4, Pages 684-690 (October 2011)
ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease 
Jean-Jacques Patard, Geraldine Pignot, Bernard Escudier, Tim Eisen, Axel Bex, Cora Sternberg, Brian Rini, Jan Roigas, Toni Choueiri, Ronald Bukowski, Robert Motzer, Ziya Kirkali, Peter Mulders, Joaquim Bellmunt 
European Urology 
Volume 60, Issue 4, Pages (October 2011)
DOI: /j.eururo
Copyright © 2011 European Association of Urology Terms and Conditions

2. Fig. 1
Treatment schematic for patients with metastatic clear-cell renal cell carcinoma in the first-line setting.
IL-2=interleukin-2; IFN-α=interferon-α.
European Urology  , DOI: ( /j.eururo )
Copyright © 2011 European Association of Urology Terms and Conditions

3. Fig. 2
Treatment schematic for patients with metastatic clear-cell renal cell carcinoma in the second-line setting.
VEGF=vascular endothelial growth factor; mTOR=mammalian target of rapamycin; TKI=multi–tyrosine kinase inhibitor.
European Urology  , DOI: ( /j.eururo )
Copyright © 2011 European Association of Urology Terms and Conditions